ArticleAntibody therapeutics2026

DOTAM-TCB: Universal Small Molecule-guided Hapten- and T Cell-bispecific Antibodies for Cancer Immunotherapy.

Marlena Surowka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.